Provided by Tiger Trade Technology Pte. Ltd.

Bausch + Lomb Corp.

17.11
+0.17001.00%
Post-market: 17.110.00000.00%19:30 EDT
Volume:354.10K
Turnover:6.04M
Market Cap:6.10B
PE:-35.55
High:17.16
Open:17.13
Low:16.80
Close:16.94
52wk High:18.92
52wk Low:13.77
Shares:356.38M
Float Shares:45.50M
Volume Ratio:1.09
T/O Rate:0.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4814
EPS(LYR):-1.0200
ROE:-2.52%
ROA:1.83%
PB:0.96
PE(LYR):-16.77

Loading ...

Bausch + Lomb Launches AI-Powered Digital Health Platform Orphia to Refocus Eye Care on Patient Treatment

Deep News
·
Jul 09

Bausch + Lomb introduces Orphia AI-powered digital health platform

TIPRANKS
·
Jul 09

Bausch + Lomb price target raised to $21 from $19 at Citi

TIPRANKS
·
Jul 08

Citi Keeps Their Buy Rating on Bausch + Lomb Corporation (BLCO)

TIPRANKS
·
Jul 08

Bausch + Lomb Schedules Q2 2026 Financial Results Release for July 29

Deep News
·
Jul 06

Bausch + Lomb Survey Links Dry Eye Symptom Treatment to Improved Quality of Life, Lower Anxiety

Reuters
·
Jul 01

Assessing Bausch + Lomb (NYSE:BLCO) Valuation After Recent Share Price Weakness And Governance Concerns

Simply Wall St.
·
Jun 01

Bausch + Lomb joins Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
May 21

Bausch + Lomb shareholders elected directors at annual meeting

Reuters
·
May 21

Better Futures raises EUR 600,000 from Enterprise Ireland, angel investors

Reuters
·
May 20

Bausch + Lomb announces U.S. launch of PreserVision AREDS3

TIPRANKS
·
May 19

A Look At Bausch + Lomb (BLCO) Valuation After Bi Blade Plus Launch In European Surgical Market

Simply Wall St.
·
May 11

Bausch + Lomb launches Bi-Blade+ dual-port vitrectomy cutter in Europe

TIPRANKS
·
May 07

Bausch + Lomb to host R&D teach-in webinar on contact lens pipeline

Reuters
·
May 06

H.C. Wainwright Remains a Buy on Bausch + Lomb Corporation (BLCO)

TIPRANKS
·
May 04

Bausch + Lomb presents Phase 2 trial data for BL1107 glaucoma drug at ARVO 2026

Reuters
·
Apr 30

Bausch + Lomb Q1 Adjusted EPS USD 0.05 Vs. IBES Estimate USD 0.06

Reuters
·
Apr 29

GUIDANCE: (BLCO) Bausch + Lomb Expects 2026 Revenue Range $5.42B - $5.52B, vs. FactSet Est of $5.44B

MT Newswires Live
·
Apr 29

Bausch & Lomb Q1 Adj. EPS $0.08 Beats $0.06 Estimate, Sales $1.244B Beat $1.218B Estimate

Benzinga Earnings
·
Apr 29

Bausch + Lomb Q1 FY26 net loss narrows to $71 million; revenue rises 9% to $1.24 billion

Reuters
·
Apr 29